CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis.
CD133 has recently been reported as a marker of cancer stem-like cells in colorectal cancer (CRC). However, its predictive value in CRC still remains controversial. In this study, we aimed to evaluate the association between the expression of CD133 and clinicopathological features and the outcome of...
Main Authors: | Shicai Chen, Xinming Song, Zhihui Chen, Xinxin Li, Mingzhe Li, Haiying Liu, Jianchang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3569427?pdf=render |
Similar Items
-
Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
by: Wang Ke, et al.
Published: (2012-12-01) -
Role of CD133 in colorectal cancer
by: Ahmed, Tarek Mohamed Abdel Moneim Mohamed Elsaba
Published: (2011) -
Association between CD133 expression and clinicopathological profile in colorectal cancer
by: Imelda Rey, et al.
Published: (2020-08-01) -
Expression of CD133 and E-cadherin in the formation of human colorectal cancer organoids
by: Lee, Yi-Ting, et al.
Published: (2019) -
CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
by: Xiaobo Cai, et al.
Published: (2018-03-01)